Valeant Pharmaceuticals to Present at Lazard Capital Markets 5th Annual Healthcare Conference

Valeant Pharmaceuticals International (NYSE: VRX) today announced members of its senior management team will make a presentation at the Lazard Capital Markets 5^th Annual Healthcare Conference on Wednesday, November 19, 2008 at 11:00 a.m. EST. The conference will be held at The St. Regis, New York, NY.

A live webcast and audio archive of the presentation will be available on the company’s Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation’s start time to visit the site and download any streaming media software needed to listen to the Internet webcast. The webcast also can be accessed through the following URL: http://www.wsw.com/webcast/lz5/vrx/

About Valeant

Valeant Pharmaceuticals International (NYSE:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at www.valeant.com.